Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)

HKG:2185 Revenue

Shanghai Bio-heart Biological Technology had revenue of 14.38M CNY in the half year ending June 30, 2026. This brings the company's total for the last twelve months to 38.45M, up 84.29% year-over-year. In the year 2025, Shanghai Bio-heart Biological Technology had annual revenue of 44.93M. That makes Shanghai Bio-heart Biological Technology the 39,580th largest company in the world by revenue and 2,412th in Hong Kong.

• Revenue (ttm): 38.45M CNY
• Revenue Growth: +84.29%
• P/S Ratio: 5.37
• Revenue / Employee: 610.27K CNY
• Employees: 63
• Market Cap: 238.55M HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	44.93M	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 1, 2026

Data Sources Report a data error